A study in JAMA Network Open shows RT-PCR genotyping assays as a faster, cost-effective alternative to WGS for SARS-CoV-2 variant surveillance, offering high accuracy and scalability.
EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage – Pharmaceutical Technology
The EMA’s CHMP gave a positive opinion for a Wegovy label expansion, allowing the therapy’s use for the reduction of cardiovascular events such as heart